Andrea Hemmerlin

Dr. Andrea Hemmerlin

Institut de biologie moléculaire des plantes, CNRS, Strasbourg, Grand Est, France
orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2003 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
AHAndrea Hemmerlin
Andrea Hemmerlin
JHJean-François Hoeffler
Jean-François Hoeffler
OMOdile Meyer
Odile Meyer
DTDenis Tritsch
Denis Tritsch
IKIsabelle A. Kagan
Isabelle A. Kagan
TBThomas J. Bach
Thomas J. Bach
In plants, two pathways are utilized for the synthesis of isopentenyl diphosphate, the universal precursor for isoprenoid biosynthesis. The key enzyme of the cytoplasmic mevalonic acid (MVA) pathway is 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGR). Treatment of Tobacco Bright Yellow-2 (TBY-2) cells by the HMGR-specific inhibitor mevinolin led to growth reduction and induction of apparent HMGR activity, in parallel to an increase in protein representing two HMGR isozymes. Maximum induction was observed at 24 h. 1-Deoxy-d-xylulose (DX), the dephosphorylated first precursor of the plastidial 2-C-methyl-d-erythritol 4-phosphate (MEP) pathway, complemented growth inhibition by mevinolin in the low millimolar concentration range. Furthermore, DX partially re-established feedback repression of mevinolin-induced HMGR activity. Incorporation studies with [1,1,1,4-2H4]DX showed that sterols, normally derived from MVA, in the presence of mevinolin are synthesized via the MEP pathway. Fosmidomycin, an inhibitor of 1-deoxy-d-xylulose-5-phosphate reductoisomerase, the second enzyme of the MEP pathway, was utilized to study the reverse complementation. Growth inhibition by fosmidomycin of TBY-2 cells could be partially overcome by MVA. Chemical complementation was further substantiated by incorporation of [2-13C]MVA into plastoquinone, representative of plastidial isoprenoids. Best rates of incorporation of exogenous stably labeled precursors were observed in the presence of both inhibitors, thereby avoiding internal isotope dilution.

1 April 2012 in Progress in Lipid Research
Verified
Journal Article
Closed access
AHAndrea Hemmerlin
Andrea Hemmerlin
JHJohn Harwood
John Harwood
TBThomas J. Bach
Thomas J. Bach

1 September 2016 in Biotechnology Advances
Verified
Journal Article
Closed access
PLPan Liao
Pan Liao
AHAndrea Hemmerlin
Andrea Hemmerlin
TBThomas J. Bach
Thomas J. Bach
MCMee-Len Chye
Mee-Len Chye


15 April 1998 in Biochemical Journal
Verified
Journal Article
Open access
PDF file
ADAndrea Disch
Andrea Disch
AHAndrea Hemmerlin
Andrea Hemmerlin
TBThomas J. Bach
Thomas J. Bach
MRMichel Rohmer
Michel Rohmer
Study of the incorporation of 13C-labelled glucose or pyruvate into the isoprenoids of tobacco BY-2 cells allowed the biosynthetic origin of isopentenyl diphosphate to be determined. Sterols synthesized in the cytoplasm and the prenyl chain of ubiquinone Q10 located in mitochondria were derived from the same isopentenyl diphosphate pool, synthesized from acetyl-CoA through mevalonate, whereas the prenyl chain of plastoquinone was obtained from the mevalonate-independent glyceraldehyde 3-phosphate/pyruvate route, like all chloroplast isoprenoids from higher plants. These results are in accord with the compartmentation and complete enzymic independence of the biosynthesis of long-chain all-trans polyprenols in mitochondria and chloroplasts.

8 February 2005 in Biochemical Journal
Verified
Journal Article
Closed access
LKLionel Kuntz
Lionel Kuntz
DTDenis Tritsch
Denis Tritsch
CGCatherine Grosdemange-Billiard
Catherine Grosdemange-Billiard
AHAndrea Hemmerlin
Andrea Hemmerlin
AWAudrey Willem
Audrey Willem
MRMichel Rohmer
Michel Rohmer
Isoprenoid biosynthesis via the methylerythritol phosphate pathway is a target against pathogenic bacteria and the malaria parasite Plasmodium falciparum. 4-(Hydroxyamino)-4-oxobutylphosphonic acid and 4-[hydroxy(methyl)amino]-4-oxobutyl phosphonic acid, two novel inhibitors of DXR (1-deoxy-D-xylulose 5-phosphate reducto-isomerase), the second enzyme of the pathway, have been synthesized and compared with fosmidomycin, the best known inhibitor of this enzyme. The latter phosphonohydroxamic acid showed a high inhibitory activity towards DXR, much like fosmidomycin, as well as significant antibacterial activity against Escherichia coli in tests on Petri dishes.